Insider Trading - venBio Global Strategic Fund II L.P.

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for venBio Global Strategic Fund II L.P.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2017-11-13
Purchase
2017-11-13
4:27 pm
Apellis Pharmaceuticals Inc. APLS venBio Global Strategic Fund II L.P.
10% Owner
127,515 $14 $1,785,210 3,579,305
(Direct)
View
2018-01-25
Purchase
2018-01-29
4:22 pm
Menlo Therapeutics Inc. MNLO venBio Global Strategic Fund II L.P.
10% Owner
265,000 $17 $4,505,000 1,461,552
(Direct)
View
2019-06-24
Purchase
2019-06-25
09:20 am
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
250,000 $16 $4,000,000 3,954,858
(Indirect)
View
2019-12-31
Sale
2020-01-03
4:13 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
14,324 $23.96 $343,259 3,940,534
(Indirect)
View
2020-01-02
Sale
2020-01-06
4:07 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
35,498 $19.71 $699,721 3,905,036
(Indirect)
View
2020-01-06
Sale
2020-01-08
4:10 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
73,221 $19.86 $1,454,530 3,831,815
(Indirect)
View
2020-01-08
Sale
2020-01-10
4:06 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
15,677 $19.86 $311,355 3,816,138
(Indirect)
View
2020-01-13
Sale
2020-01-14
08:58 am
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
494,000 $20.23 $9,993,620 3,322,138
(Indirect)
View
2020-02-04
Sale
2020-02-06
4:06 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
82,339 $25.77 $2,121,726 3,239,799
(Indirect)
View
2020-02-06
Sale
2020-02-10
5:47 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
6,102 $27.03 $164,955 3,233,697
(Indirect)
View
2020-02-11
Sale
2020-02-12
5:56 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
10,026 $27.07 $271,399 3,233,671
(Indirect)
View
2020-02-25
Sale
2020-02-27
7:51 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
5,904 $22.8 $134,635 3,227,767
(Indirect)
View
2020-02-28
Sale
2020-03-03
5:52 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
21,798 $22.63 $493,310 3,195,969
(Indirect)
View
2020-03-04
Sale
2020-03-06
5:23 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
45,950 $23.76 $1,091,608 3,150,019
(Indirect)
View
2020-07-01
Sale
2020-07-06
7:00 pm
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
116,467 $34.4 $4,006,537 3,033,552
(Indirect)
View
2020-07-21
Purchase
2020-07-21
9:29 pm
ALX ONCOLOGY HOLDINGS INC ALXO Adelman Robert J
venBio Global Strategic Fund L.P.
venBio Global Strategic GP Ltd.
venBio Global Strategic Fund II L.P.
venBio Global Strategic GP L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
10% Owner
853,000 $19 $16,207,000 5,829,542
(Indirect
Direct)
View
2020-08-11
Purchase
2020-08-12
9:00 pm
Checkmate Pharmaceuticals Inc. CMPI venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
GOODMAN COREY S
Adelman Robert J
10% Owner
200,000 $15 $3,000,000 3,673,374
(Direct)
View
2021-04-27
Purchase
2021-04-29
6:44 pm
IMPEL NEUROPHARMA INC IMPL venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
GOODMAN COREY S
Adelman Robert J
10% Owner
450,000 $15 $6,750,000 2,759,791
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2017-11-13
Conversion
2017-11-13
4:27 pm
N/A
N/A
Apellis Pharmaceuticals Inc. APLS venBio Global Strategic Fund II L.P.
10% Owner
10,814,459 $0 3,579,305
(Direct)
View
2018-01-25
Conversion
2018-01-29
4:22 pm
N/A
N/A
Menlo Therapeutics Inc. MNLO venBio Global Strategic Fund II L.P.
10% Owner
4,424,252 $0 1,461,552
(Direct)
View
2019-06-24
Conversion
2019-06-25
09:20 am
N/A
N/A
Akero Therapeutics Inc. AKRO venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
Adelman Robert J
GOODMAN COREY S
10% Owner
15,094,262 $0 3,954,858
(Indirect)
View
2020-07-21
Conversion
2020-07-21
9:29 pm
N/A
N/A
ALX ONCOLOGY HOLDINGS INC ALXO Adelman Robert J
venBio Global Strategic Fund L.P.
venBio Global Strategic GP Ltd.
venBio Global Strategic Fund II L.P.
venBio Global Strategic GP L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
10% Owner
11,062,093 $0 5,829,542
(Direct)
View
2020-08-11
Conversion
2020-08-12
9:00 pm
N/A
N/A
Checkmate Pharmaceuticals Inc. CMPI venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
GOODMAN COREY S
Adelman Robert J
10% Owner
28,371,348 $0 3,673,374
(Direct)
View
2021-04-22
Other
2021-04-26
7:11 pm
N/A
2021-12-31
IMPEL NEUROPHARMA INC IMPL venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
GOODMAN COREY S
Adelman Robert J
10% Owner
1,359,799 $0 1,359,799
(Direct)
View
2021-04-27
Conversion
2021-04-29
6:44 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL venBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
GOODMAN COREY S
Adelman Robert J
10% Owner
39,827,381 $0 2,759,791
(Direct)
View